A randomised open labeled, parallel-group, controlled trial to assess the efficacy of paracetamol to reduce kidney dysfunction caused by cell-free haemoglobin-mediated oxidative damage in paediatric patients with falciparum malaria complicated by intravascular haemolysis.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Acute kidney injury (AKI) or death among patients enrolled without AKI (Composite outcome)
Timeframe: during first 7 days of enrolment
Acute kidney injury (AKI) progression or death among patients enrolled with AKI (Composite outcome)
Timeframe: during first 7 days of enrolment